Position in RVMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$99,418,480
-$29,115,114 QoQ
Shares Held
1,022,298
-36.6% QoQ
Ownership
0.481%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
17 quarters on record
Voting authority
Sole 99.95109058219815.ToString("F0")%
Shared 0.ToString("F0")%
None 0.04890941780185425.ToString("F0")%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Derivatives in RVMD
reported options exposure · as of Mar 31, 2026CallValue
$3,034,200
CallShares
31,200
PutValue
$2,431,250
PutShares
25,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. RVMD ranks #10 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,625,825 | $919,934,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,059,062 | $350,411,843 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
2,545,486 | $189,027,789 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
2,865,318 | $166,503,628 | |
| 5 | EXEL |
Exelixis, Inc.
|
3,603,063 | $154,535,371 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,868,708 | $120,774,597 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
1,640,381 | $111,759,157 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
248,960 | $111,170,598 |
All Filings in RVMD
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $99,418,480 | 1,022,298 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $2,431,250 | 25,000 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $3,034,200 | 31,200 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $128,533,594 | 1,613,730 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $37,933,428 | 812,279 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $24,286,255 | 660,132 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $648,707 | 14,831 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,814,407 | 40,009 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,136,899 | 29,294 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,373,964 | 73,657 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,464,773 | 51,073 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $20,629,100 | 745,271 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $11,865,604 | 443,574 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,263,402 | 196,833 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,478,602 | 62,074 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,712,407 | 188,256 | Shares | Defined | 2022-11-14 | |
| 2021-12-31 | $491,846 | 19,541 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $555,196 | 17,492 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $954,716 | 20,809 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||